Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy

Per Karlsson, Bernard F. Cole, Marco Colleoni, Mario Roncadin, Boon H. Chua, Elizabeth Murray, Karen N. Price, Monica Castiglione-Gertsch, Aron Goldhirsch, Günther Gruber

Research output: Contribution to journalArticle

Abstract

Purpose: To evaluate the association between the interval from breast-conserving surgery (BCS) to radiotherapy (RT) and the clinical outcome among patients treated with adjuvant endocrine therapy. Patients and Methods: Patient information was obtained from three International Breast Cancer Study Group trials. The analysis was restricted to 964 patients treated with BCS and adjuvant endocrine therapy. The patients were divided into two groups according to the median number of days between BCS and RT and into four groups according to the quartile of time between BCS and RT. The endpoints were the interval to local recurrence, disease-free survival, and overall survival. Proportional hazards regression analysis was used to perform comparisons after adjustment for baseline factors. Results: The median interval between BCS and RT was 77 days. RT timing was significantly associated with age, menopausal status, and estrogen receptor status. After adjustment for these factors, no significant effect of a RT delay ≤20 weeks was found. The adjusted hazard ratio for RT within 77 days vs. after 77 days was 0.94 (95% confidence interval [CI], 0.47-1.87) for the interval to local recurrence, 1.05 (95% CI, 0.82-1.34) for disease-free survival, and 1.07 (95% CI, 0.77-1.49) for overall survival. For the interval to local recurrence the adjusted hazard ratio for ≤48, 49-77, and 78-112 days was 0.90 (95% CI, 0.34-2.37), 0.86 (95% CI, 0.33-2.25), and 0.89 (95% CI, 0.33-2.41), respectively, relative to ≥113 days. Conclusion: A RT delay of ≤20 weeks was significantly associated with baseline factors such as age, menopausal status, and estrogen-receptor status. After adjustment for these factors, the timing of RT was not significantly associated with the interval to local recurrence, disease-free survival, or overall survival.

Original languageEnglish
Pages (from-to)398-402
Number of pages5
JournalInternational Journal of Radiation Oncology Biology Physics
Volume80
Issue number2
DOIs
Publication statusPublished - Jun 1 2011

    Fingerprint

Keywords

  • Breast cancer
  • Breast-conserving surgery
  • Endocrine therapy
  • Radiotherapy
  • Radiotherapy timing

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Karlsson, P., Cole, B. F., Colleoni, M., Roncadin, M., Chua, B. H., Murray, E., Price, K. N., Castiglione-Gertsch, M., Goldhirsch, A., & Gruber, G. (2011). Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy. International Journal of Radiation Oncology Biology Physics, 80(2), 398-402. https://doi.org/10.1016/j.ijrobp.2010.02.042